The first production unit of recombinant and biological protein drugs (for especial patients) created by Iranian experts was exploited in Turkey.

According to the public relations and information center of the Vice-Presidency for science and technology affairs The first production unit of recombinant and biological protein drugs (for especial patients) created by Iranian experts was exploited in Turkey in the presence of Esmaeil Ghaderifar, head of the strategic technologies development center, Mohammad Farazmand, ambassador of Iran in Turkey, minister of health of turkey, governorate of Istanbul and a number of local authorities and managers of the Iranian knowledge-based Cinnagen Co. in industrial town of Tekirdağ in Turkey.

The head of the strategic technologies development headquarter regarded this factory the largest bio-pharmaceutical company of the MENA region (Middle East and North of Africa).

Pointing out that an Iranian knowledge-based company has been able to eliminate all barriers and establish a knowledge-based factory in this country for the first time in the history of pharmacy industry of Iran, Ghaderifar asserted: the Vice-Presidency has seriously determined to develop the export of Iranian knowledge-based products.

He also mentioned: the programs of the international affairs and technological exchange center are designed to support introducing Iranian knowledge-based products to the global markets.

Ghaderifar believes that efforts made by the Vice-Presidency for development of knowledge-based companies have affected the internationalization of their products and services.

Export of Iranian Drugs to 20 Countries

In addition, Farshi, the production manager of Cinnagen Ilach Co., asserted: we have experienced the production of drugs for special patients in Turkey for the first time.